IRLA$32.23-3.95%
IRulya Therapeutics Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$32.77M
Float & O/S:
Inst Own:
DilutionScan read 45 of IRulya Therapeutics Inc.'s SEC filings and found 4 warrant series, 1 convertible, 1 ATM program, 3 shelf registrations and 2 completed offerings on file for IRLA. The latest dilution event on file is a registration statement on Aug 24, 2026. Analysis updated Oct 31, 2026.
